Neuroprotective potential of escitalopram against behavioral, mitochondrial and oxidative dysfunction induced by 3-nitropropionic acid

BACKGROUND: Huntington’s disease (HD) is a neurodegenerative syndrome that leads to marked decline in cognitive functioning along with uncharacteristic body movements called chorea. There exists no therapeutic agent to address the disease.3-Nitropropionic acid (3-NP) which is a suicide inhibitor of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shetty, Shruthi, Hariharan, Ashwini, Shirole, Trupti, Jagtap, Aarti G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Academy of Neurosciences 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410522/
https://www.ncbi.nlm.nih.gov/pubmed/26124545
http://dx.doi.org/10.5214/ans.0972.7531.220104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410522/
https://www.ncbi.nlm.nih.gov/pubmed/26124545
http://dx.doi.org/10.5214/ans.0972.7531.220104

Ejemplares similares